Literature DB >> 26055560

Hypertension Screening and Follow-up Management by Primary Health Care System among Chinese Population Aged 35 Years and Above.

Ya Jing Feng1, Hui Cheng Wang2, Yi Chong Li1, Wen Hua Zhao3.   

Abstract

OBJECTIVE: To describe hypertension screening and follow-up management among Chinese population aged 35 years and above within the primary health care system.
METHODS: Data from 2010 China Chronic Disease and Risk Factor Surveillance System were used. We investigated previous hypertension diagnosis, screening, and follow-up assessments within the primary health care system. The prevalence of self-reported and criterion-based hypertension, screening rates, demographic and socioeconomic characteristics associated with screening, and patterns of follow-up assessments were recorded. The SAS software system was used for statistical analyses.
RESULTS: About 17.1% reported a previous hypertension diagnosis. The rate difference between the two measures of prevalence was 27.2%. Among those without self-reported hypertension, 27.7% reported never visiting a clinic during the past 1 year and 60.4% of those attending a clinic reported ever being screened. Younger age group was associated with lower screening proportion; odds ratios of 35-, 45-, 55-, and ⋝65 years were 1.7 (95% CI: 1.5-1.9), 1.5 (95% CI: 1.3-1.7), 1.3 (95% CI: 1.2-1.4), and 1.0, respectively. About 35.1% of the patients had undergone follow-up assessments four or more times during the past 1 year.
CONCLUSION: Majority of the Chinese population aged 35 years and above, particularly the less educated, elderly population, and rural residents were unaware of that they were suffering from hypertension. Most patients did not receive enough management services by the primary health care system. Thus, strengthening both the screening and follow-up management is needed.
Copyright © 2015 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.

Entities:  

Keywords:  Hypertension; Management; Policy; Screening

Mesh:

Year:  2015        PMID: 26055560     DOI: 10.3967/bes2015.047

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  12 in total

1.  Cardiovascular Disease Mortality and Potential Risk Factor in China: A Multi-Dimensional Assessment by a Grey Relational Approach.

Authors:  Shazia Rehman; Erum Rehman; Ayesha Mumtaz; Zhang Jianglin
Journal:  Int J Public Health       Date:  2022-04-29       Impact factor: 5.100

2.  Improving the Blood Pressure Control With the ProActive Attitude of Hypertensive Patients Seeking Follow-up Services: Evidence From China.

Authors:  Shangfeng Tang; Ghose Bishwajit; Lu Ji; Da Feng; Haiqing Fang; Hang Fu; Tian Shao; Piaopiao Shao; Chunyan Liu; Zhanchun Feng; Tegene R Luba
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

3.  Dysfunction of the thymus in mice with hypertension.

Authors:  Xianliang Dai; Shuaibo Huang; Zhiqing He; Feng Wu; Ru Ding; Yihong Chen; Chun Liang; Zonggui Wu
Journal:  Exp Ther Med       Date:  2017-02-15       Impact factor: 2.447

Review 4.  Non-communicable Diseases and Cognitive Impairment: Pathways and Shared Behavioral Risk Factors Among Older Chinese.

Authors:  Vasoontara Sbirakos Yiengprugsawan; Colette Joy Browning
Journal:  Front Public Health       Date:  2019-10-23

5.  The status and predictors of self-care among older adults with hypertension in China using the Chinese version of Self-Care of Hypertension Inventory - A cross-sectional study.

Authors:  Yu-Jie Guo; Xiao-Yun Hu; Hong-Juan Ji; Qiao Zhao; Long-Yuan Wang; Xiao-Yan Zhou; Jue Tang; Lei Yang; Xiang-Chao Sun
Journal:  Nurs Open       Date:  2022-01-11

Review 6.  Non-communicable diseases control in China and Japan.

Authors:  Fei Wu; Hiroto Narimatsu; Xiaoqiang Li; Sho Nakamura; Ri Sho; Genming Zhao; Yoshinori Nakata; Wanghong Xu
Journal:  Global Health       Date:  2017-12-20       Impact factor: 4.185

7.  Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States.

Authors:  Yuan Lu; Pei Wang; Tianna Zhou; Jiapeng Lu; Erica S Spatz; Khurram Nasir; Lixin Jiang; Harlan M Krumholz
Journal:  J Am Heart Assoc       Date:  2018-01-26       Impact factor: 5.501

8.  Trajectories of Outpatient Service Utilisation of Hypertensive Patients in Tertiary Hospitals in China.

Authors:  Zijing Pan; Wanchun Xu; Zhong Li; Chengzhong Xu; Fangfang Lu; Pei Zhang; Liang Zhang; Ting Ye
Journal:  Int J Environ Res Public Health       Date:  2020-01-29       Impact factor: 3.390

Review 9.  Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries:a scoping review.

Authors:  Jorge César Correia; Sarah Lachat; Grégoire Lagger; François Chappuis; Alain Golay; David Beran
Journal:  BMC Public Health       Date:  2019-11-21       Impact factor: 3.295

Review 10.  Hypertension in China: burdens, guidelines and policy responses: a state-of-the-art review.

Authors:  Ruoyu Yin; Lishi Yin; Lin Li; Jennifer Silva-Nash; Jingru Tan; Zixian Pan; Jianying Zeng; Lijing L Yan
Journal:  J Hum Hypertens       Date:  2021-07-02       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.